Difference between revisions of "Factor X, human (Coagadex)"
Jump to navigation
Jump to search
(Created page with "==General information== Class/mechanism: Factor X; replaces the missing clotting factor X that is required for hemostasis in patients with inherited or acquired factor X defic...") |
Warner-admin (talk | contribs) m (Text replacement - "please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [https://online.lexi.com/lco/action/login UpToDate Lexidrug], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information" to "please refer to your preferred pharmacopeias or the prescribing information") |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
Class/mechanism: Factor X; replaces the missing clotting factor X that is required for hemostasis in patients with inherited or acquired factor X deficiency. | Class/mechanism: Factor X; replaces the missing clotting factor X that is required for hemostasis in patients with inherited or acquired factor X deficiency. | ||
| − | Route: IV | + | <br>Route: IV |
<br>Extravasation: no information | <br>Extravasation: no information | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information. |
==Also known as== | ==Also known as== | ||
| Line 14: | Line 14: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Fractionated plasma products]] | [[Category:Fractionated plasma products]] | ||
| + | [[Category:Inherited coagulopathy medications]] | ||
[[Category:Hemostasis medications]] | [[Category:Hemostasis medications]] | ||
[[Category:Coagulation factors]] | [[Category:Coagulation factors]] | ||
[[Category:Hematology medications]] | [[Category:Hematology medications]] | ||
Latest revision as of 01:01, 29 June 2024
General information
Class/mechanism: Factor X; replaces the missing clotting factor X that is required for hemostasis in patients with inherited or acquired factor X deficiency.
Route: IV
Extravasation: no information
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.
Also known as
- Brand name: Coagadex